Jonathan Dixon V

Jonathan Dixon V discloses dealings in Bionano Genomics, Inc. to SEC (Form 4). Over a trading history stretching from 15 February 2024 to 3 June 2026, the count stands at 6 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 3 June 2026, the filings show a share grant worth €27 in Bionano Genomics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.